Golgi Phosphoprotein 4 as a Highly Sensitive and Specific Indicator of Manganese Exposure in Neuronal Cells

Chronic exposure to elevated manganese levels is increasingly recognized as a significant risk factor for neurocognitive and motor impairments, particularly in children. Despite this, the cellular mechanisms underlying manganese toxicity remain poorly understood, especially during the transition from physiological to toxic exposure levels. This study investigates Golgi Phosphoprotein 4 (GPP130) as a potential biomarker of manganese exposure in AF5 GABAergic neuronal cells, focusing on its specificity, sensitivity, and temporal dynamics. Our findings demonstrate that GPP130 degradation is highly specific to manganese among various divalent cations, including cobalt, copper, iron, nickel, and zinc, with no detectable degradation observed under any of these alternative exposures. Notably, GPP130 degradation occurs rapidly—within one hour of manganese exposure—and at remarkably low concentrations: as little as 0.54 µM Mn, which is approximately 200 times lower than previously reported thresholds. Crucially, this response occurs without measurable increases in intracellular manganese levels, indicating that GPP130 degradation is not a consequence of accumulated metal but rather an early signaling event in response to extracellular manganese flux.

Further analysis reveals that GPP130 degradation follows a biphasic pattern: initial rapid loss coincides with a transient spike in intracellular Mn, followed by a decline in both Mn levels and GPP130 protein over time, even under continued exposure. This suggests that GPP130 may play a regulatory role in manganese homeostasis, possibly facilitating efflux or redistribution. Recovery studies show that while GPP130 levels begin to rebound after cessation of exposure, recovery is slow and incomplete, underscoring the persistence of the cellular stress response.Neurogranin Proteinmedchemexpress In vivo validation in rats subchronically exposed to manganese via intraperitoneal injection (9.6 mg/kg/day, three times weekly for four weeks) confirms the relevance of these findings. Control animals exhibit GPP130 immunoreactivity in only 15–30% of striatal and cortical neurons, consistent with selective expression. After manganese exposure, there was a significant reduction in both the number of GPP130-positive cells and total protein levels across brain regions, confirming that GPP130 degradation is not limited to cell culture but reflects a real biological response in the intact nervous system.

These results establish GPP130 as a highly sensitive and specific cellular indicator of manganese exposure, capable of detecting perturbations at physiologically relevant levels.1,4-Dibromo-2,5-diiodobenzene site Its rapid, Mn-specific degradation provides insight into early molecular events in manganese neurotoxicity and supports a potential role in cellular manganese regulation.PMID:35094932 Given that GPP130 is involved in endosome-to-Golgi trafficking, its disruption may impair critical protein sorting pathways, contributing to functional deficits. Moreover, the observation that some neurons maintain GPP130 despite exposure suggests differential susceptibility across cell populations, potentially explaining regional vulnerability in manganese-induced neurotoxicity. These findings highlight GPP130 as a promising target for monitoring environmental manganese exposure and understanding early mechanisms of brain injury.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com